Coming of age of bevacizumab in the management of radiation-induced cerebral necrosis
Ann Transl Med
.
2019 Apr;7(7):155.
doi: 10.21037/atm.2019.03.17.
Authors
Melvin L K Chua
1
2
3
,
Kevin L M Chua
1
3
,
Joseph T S Wee
1
3
Affiliations
1
Division of Radiation Oncology, National Cancer Centre Singapore, Singapore.
2
Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
3
Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore.
PMID:
31157276
PMCID:
PMC6511557
DOI:
10.21037/atm.2019.03.17
No abstract available
Publication types
Editorial
Comment